Marshall Wace’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Marshall Wace’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,773	Closed	-$1.01M	–	3884
2022 Q3	$1.01M	Buy	50,773 +16,631	+49%	+$219K	﹤0.01%	2404
2022 Q2	$236K	Buy	+34,142	New	+$240K	﹤0.01%	3110
2022 Q1	–	Sell	-4,631	Closed	-$66K	–	4320
2021 Q4	$66K	Buy	+4,631	New	+$80.1K	﹤0.01%	3491
2021 Q1	–	Sell	-15,089	Closed	-$526K	–	3007
2020 Q4	$526K	Buy	+15,089	New	+$657K	﹤0.01%	1436

Marshall Wace's FMTX Position: Q4 2022 in Review

Marshall Wace sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 50,773 shares — an estimated $1.01M sold.

Marshall Wace first reported a position in FMTX in Q4 2020 and held it in 4 quarters. The position peaked at $1.01M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Marshall Wace reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 50,773 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.01M.
Marshall Wace first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Marshall Wace's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.01M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.